Egis in the World

Our products are available in 61 countries

Click here to learn more

Pharma Company

Our activities incorporate all areas of the pharmaceutical value chain

Click here to learn more

Research & Development

Innovation is one of the pillars of our strategy. We devote approximately EUR 45 million to research and development.

Click here to learn more
Own subsidiaries / Representative offices
Sales through Partners

Egis in the World

Our products are available in 61 countries

Egis ’products are available in 61 countries. Our portfolio consists of 634 products.  Our main focus lies on treating diseases of the cardiovascular and central nervous systems. 

Learn more

A place to work

Join us!

VPOIS

PUBLIC ACCESSIBLE PROFESSIONAL INFORMATION SERVICE.

Please find all info here

Learn more
Main therapeutic areas
Main therapeutic areas
Cardiovascular system
Central nervous system
Gastroenterology
Oncology
Women´s health

Pharmacovigilance, Adverse event reporting

Please report any adverse events possibly related to the products of Egis Pharmaceuticals PLC.

WarningYour browser is out of date. Please, use an updated version! Chrome || Firefox